West Pharmaceutical Services WST Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's operating cash flow?
- West Pharmaceutical Services (WST) reported operating cash flow of $89.9M in Q1 2026.
- How has West Pharmaceutical Services's operating cash flow changed year-over-year?
- West Pharmaceutical Services's operating cash flow decreased by 30.5% year-over-year, from $129.4M to $89.9M.
- What is the long-term trend for West Pharmaceutical Services's operating cash flow?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's operating cash flow has grown at a 6.6% compound annual growth rate (CAGR), from $584M to $754.8M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.